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ABSTRACT
Objective: To evaluate the demographic characteristics and imaging findings of throm-
bosis in a series of patients submitted to endovascular stent-graft repair of abdominal 
aortic aneurysm (ESGAAA). Methods: We evaluated the imaging features, which al-
lowed the diagnosis of endoluminal thrombosis in a series of 30 patients undergoing 
ESGAAA and followed from 5 to 29 months, using 64-channel multidetector computed 
tomography (MDCT). Results: Thrombosis was diagnosed in 10 patients (33.3%), and 
in 3 of those patients, total thrombosis was observed in an iliac branch. Conclusion: 
MDCT allowed the diagnosis of different types of endoluminal thrombosis in patients 
submitted to ESGAAA. The use of this minimally invasive diagnostic technique should 
be encouraged in clinical practice.
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INTRODUCTION
 Until the early 90’s, open surgery was the only treatment 
for abdominal aortic aneurysm (AAA), with periopera-
tive mortality rate for patients undergoing elective sur-
gery ranging from 4% to 8.4% in specialized centers1,2,3. 
The continuous search for surgical techniques with lower 
mortality and morbidity rates led to the development of 
endovascular prosthesis and techniques to treat abdomi-
nal aortic aneurysm. They have been used in different re-
gions of the world, being approved by the United States 
Food and Drug Administration (FDA) since 19994,5.
Endovascular surgery for AAA repair is not devoid 
of complications, which can develop during or after the 
procedure. However, the choice of this treatment modal-
ity has been justified when compared to conventional 
surgery1. Parietal thrombosis may develop as a small 
circumferential thrombus on graft’s wall, or as a luminal 
occlusion of the stent, demonstrated in digital angiogra-
phy (DA) or computed tomography (CT), with an esti-
mated incidence of 3-19% of the cases of endovascular 
stent-graft repair of abdominal aortic aneurysm (ES-
GAAA)6,7,8,9,10,11.
Using a 64-channel multidetector CT (MDCT), we 
investigated a series of consecutive patients who under-
went ESGAAA in order to assess the demographic char-
acteristics and images of endoluminal thrombosis.
METHODS
PATIENTS
This transversal study was approved by the Research Eth-
ics Committee of the Institution, and all patients signed 
an informed consent. From February to September 2007, 
30 consecutive patients followed-up after ESGAAA (26 
males and 4 females), ages 55 to 83 years (mean 70.9 
years, median 72 years), were included in this study. All 
patients agreed to participate in the study. The follow-
up period ranged from 5 to 29 months after surgery 
(mean 14.4 months, median 13.5 months). The proposed 
followed-up protocol included MDCT at 1, 3, 6, and 12 
months in the first year after the surgery, followed by an-
nual MDCT in cases with aneurism regression or stabil-
ity. In those cases in which expansion on the aneurysm 
was observed, patients were followed-up with MDCT 
every three months. All patients were treated with aorto-
iliac abdominal stent grafts of the following brands: Tal-
ent®, Meditronic Vascular, Sunrise, Fla (n = 18); Excluder 
endoprothesis®, W.L. Gore & Associates, Sunnyvale, Calif 
(n = 1); Zenith®, Cook Inc, Bloomington, Ind (n = 8); and 
Apolo®, Nano Endoluminal, Florianópolis, Brasil (n = 3). 
To analyze the development of endoluminal thrombosis, 
grafts were grouped according to their material, and they 
were separated in Polytetrauorethylene (PTFE) (Apolo® 
and Excluder endoprosthesis®) and Dacron/Polyester (Tal-
ent® and Zenith®).
Patients who refused to participate, and those who 
presented contraindications to the injection of iodinated 
contrast media or exams with ionizing radiation, as well 
as those with renal failure were excluded from the study.
EXAMS
MDCT 64-channel Brilliance equipment (Phillips, 
Eindhoven, Holland) was used for the exams. The 
exam covered the area between the diaphragm and 
common femoral arteries in three phases: pre-contrast, 
with collimation of 2.5 mm, 120 Kv, and 322 mAs; and 
post-contrast, arterial and venous phases, both with 
acquired collimation of 0.625 mm and reconstructed 
with 1.0 mm thickness, increment of 1.0 mm, Pitch of 
0.703, rotation velocity of 0.75 per second, 120 Kv, and 
350 mAs.
A dose of 1.5 mL/kg of contrast medium (mean of 
100 ml per patient), with concentration of 300 mg of 
iodine per ml, was injected through a venous puncture 
with a 20-Gauge catheter in the antecubital vein, with 
an infusion pump at a rate of 5 ml per second, followed 
by 30 ml of normal saline. Post-contrast administra-
tion phases were performed using an attenuation de-
tector mechanism placed in the area of the aorta, at 
the level of the celiac branch (bolus tracker) that, when 
reached 180 Hounsfield units (HU) determined by the 
arrival of the contrast medium, began scanning the ar-
terial phase, followed by the venous phase attained 60 
seconds after the first one. In all phases, apnea time 
ranged from 12 to 18 seconds.
IMAGE ANALYSIS
All images were independently analyzed at a worksta-
tion (GE Medical Systems, Milwaukee, WI) by two ra-
diologists (RMB and RB), with 11 and 15 years experi-
ence, respectively, and final results were obtained by 
consensus.
Data related to the integrity of the stents, presence 
or absence of luminal thrombus, characteristics and lo-
cation of thrombus, as well as information related to 
the type of stent and its constituents were analyzed. 
All arterial phase images were used for tridimensional 
angiographic reconstitutions using appropriate volume 
rendering (VR) and maximum intensity projection 
(MIP) reconstruction algorithms.
STATISTICAL ANALYSIS
To determine the site were thrombi are formed, the in-
cidence and percentage were calculated. Fisher’s exact 
test was used to compare the occurrence of thrombo-
sis with stent’s brand, as well as the group of stents ac-
cording to the constituent material, formed by PTFE 
(Apolo® and Excluder endoprosthesis®) and Dacron/
Polyester (Talent® and Zenith®).
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Figure 1 – Axial MDCT images showing a semi-
circumferential thrombus on the anterior internal wall 
of aortic endoprosthesis (A); right common iliac artery 
aneurysm associated with occlusion of the endoprosthesis 
and presence of an occluder in the right internal iliac artery 
(B and C); and angiographic reconstruction with volume 
rendering algorithm (D). Note the absence of contrast 
column in the right common iliac artery and the presence 
of a patent crossed femorofemoral graft (D).
RESULTS
All prosthesis used were intact and without signs of frac-
ture on MDCT. Ten cases (33.3%) of endoluminal throm-
bosis were identified. Five of those (16.7%) showed partial 
aortic thrombosis; one (3.3%) had partial thrombosis of 
the aorta and right iliac branch; one (3.3%) had partial 
thrombosis of the right iliac branch; and three (10%) had 
partial thrombosis of the aorta and total thrombosis of the 
right iliac branch (Figure 1). Data are presented in Table 1.
All patients with complete right iliac branch thrombo-
sis were smokers and had been treated for aneurysms of 
external iliac arteries by placing stent extensions and oc-
cluders of the internal iliac arteries. In two of them, throm-
bosis was diagnosed between 30 and 60 days after surgery, 
requiring surgical limb revascularization with crossed 
femorofemoral graft. The other patient presented throm-
bosis, diagnosed on control exam at six months, evolving 
with retroperitoneal and abdominal collateral circulation, 
without the need of new surgery.
Out of the 10 patients with endoluminal thrombosis, 
8 were smokers, 2 had DM, and 1 had hypertension. No 
statistically significant relationship between the presence 
of thrombosis and these clinical conditions was identified 
using Fisher’s exact test.
Among the brands of prosthesis associated with 
thrombosis, it was identified 1 case with Apolo®, 7 with 
Talent®, and 2 with Zenith®. A statistically significant dif-
ference in the presence of thrombosis among the brands 
was not observed.
Among the group of materials, one case of thrombosis 
in PTFE prosthesis (Apolo® and Excluder endoprosthesis®) 
and 9 cases in Dacron/Polyester prosthesis (Talent® and 
Zenith®) were identified. A significant difference in the 
presence of thrombosis among the material of the pros-
thesis was not observed.
DISCUSSION
Endoluminal vascular prosthesis thrombosis represents 
one of the main complications of ESGAAA diagnosed by 
CT scan.  Specialized literature highlights the following 
key factors determining the characteristic of stents throm-
bogenic material12, smoking, the need of adjuvant proce-
dures, and the experience of the surgical team13. According 
to Thurnher et al.14, formation of semicircular thrombi can 
occur in up to 19% of the cases, usually not determinant 
of ow changes or clinical repercussion. Our results is in 
agreement with this observation, since all seven patients 
with partial thrombosis (23.3%) remained asymptomatic 
in clinical evaluations and subsequent MDCTs.
Occlusion of the blood vessel by thrombosis, which 
has an incidence of 1.5% to 10%, in general extending to 
the iliac branch, has as main triggering factor the marked 
tortuosity of the prosthesis or even prosthesis bending 
by aneurysmal remodeling14. It has been reported that 
the evolution of luminal thrombosis may be spontaneous 
resolution of the thrombus, embolization of distal limb 
branches, or even total occlusion of blood vessel10. Accord-
ing to Schunn et al.12, bifurcated prostheses have a greater 
Prosthesis  
Intraluminal thrombosis  
No 20 (66.7%)
Yes 10 (33.3%)
Partial aortic circumference + total R iliac branch 3 (10%)
Partial aortic circumference 5 (16,7%)
Partial R iliac branch circumference 1 (3.3%)
Parietal aortic and partial R iliac branch D 1 (3.3%)
Total 30
Table 1 – Types of thrombosis
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chance of thrombosis- and embolization-related compli-
cations than tubular prostheses. The author reported an 
incidence of 10.5% of luminal thrombosis, 60% in bifur-
cated prosthesis and 13.3% in tubular prosthesis12.
In the present study, we identified an elevated rate 
of thrombosis (33%), regardless of the type of material 
or prosthesis used, which is above those reported in 
international literature.14 Despite the absence of statis-
tical significance in this case series, the literature has 
emphasized that superposition of some clinical condi-
tions, especially smoking, may contribute to endolumi-
nal thrombi formation13.
We believe that the high incidence of endoluminal 
thrombosis in this series might be due to the greater diag-
nostic accuracy of the high-resolution of the 64-channel 
MDCT images used in this study. High-resolution fine 
cuts (1.0 mm) allowed the detection of small intralumi-
nal thrombi, in addition to tridimensional angiographic 
reformatting and reconstruction using volume rendering 
(VR) and maximum intensity projection (MIP) recon-
struction algorithms. In a recent study using the same 
specification equipment and similar protocol, Thomaz et 
al.10 observed an elevated rate of luminal thrombosis in 
ESGAAA follow-up.
Specific studies on inherent particularities of the di-
agnosis and late treatment of AAA in the Brazilian popu-
lation are required. Tortuosity with greater longitudinal 
and transversal dilation of aortic aneurysm has been con-
sidered a risk factor for the development of endoluminal 
thrombosis14. Nevertheless, our results do not allow close 
evaluation of this aspect.
Despite the limitations inherent in this type of 
study, we believe that our results indicate relevant fac-
tors regarding the diagnosis of endoluminal thrombosis 
by MDCT. In the opinion of the authors, studies with 
larger series of patients, with longer follow-up, using 
the high resolution MDCT protocol, may contribute for 
better understanding of endoluminal thrombosis, be-
sides providing precise diagnostic parameters and more 
adequate therapy.
CONCLUSION
Multidetector CT allowed the diagnosis of different types 
of endoluminal thrombosis in this series of patients who 
underwent ESGAAA. The use of MDCT in clinical prac-
tice should be encouraged in order to obtain the best use 
of this minimally invasive diagnostic tool in the follow-
up and diagnosis of individuals undergoing ESGAAA.
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